Cargando…
Resolution of Angina Pectoris and Improvement of the Coronary Flow Reserve after Ranolazine Treatment in a Woman with Isolated Impaired Coronary Microcirculation
In a 61-year-old woman with well controlled arterial hypertension, hypercholesterolemia, and smoke and suffering from recurrent angina pectoris despite angiographically normal epicardial coronary vessels and maximal therapy, the replacement of nitrates with novel antiangina drug ranolazine, after 6-...
Autores principales: | Santoro, Alessandro, Schiano Lomoriello, Vincenzo, Santoro, Ciro, Muscariello, Riccardo, Galderisi, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008276/ https://www.ncbi.nlm.nih.gov/pubmed/24826280 http://dx.doi.org/10.1155/2013/343027 |
Ejemplares similares
-
Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris
por: Aldakkak, Mohammed, et al.
Publicado: (2013) -
Comparison of the efficacy and tolerability of ivabradine and ranolazine in patients of chronic stable angina pectoris
por: Chaturvedi, Aditi, et al.
Publicado: (2013) -
Early markers of right heart involvement in regular smokers by Pocket Size Imaging Device
por: Schiano-Lomoriello, Vincenzo, et al.
Publicado: (2015) -
Coronary-Cameral Fistula with Angina Pectoris
por: Cakar, Mehmet Akif, et al.
Publicado: (2010) -
The Role of Ranolazine for the Treatment of Residual Angina beyond the Percutaneous Coronary Revascularization
por: Calcagno, Simone, et al.
Publicado: (2020)